Windtree Therapeutics, Inc. (WINT) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
WINT Revenue Growth
WINT Revenue Analysis (2013–2024)
As of May 7, 2026, Windtree Therapeutics, Inc. (WINT) generated trailing twelve-month (TTM) revenue of $90,000. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, WINT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $2.8 million in 2014.
When compared to Healthcare sector peers including NKTR (-32.8% YoY), AGIO (+78.3% YoY), and PRTA (-92.8% YoY). Compare WINT vs NKTR →
WINT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| WINTCurrent | $90,000 | - | - | - | |
 NKTR | $55M | -32.8% | -18.4% | -253.7% | |
 AGIO | $54M | +78.3% | - | -873.9% | |
 PRTA | $10M | -92.8% | +62.6% | -1905.8% | |
 ACAD | $1.1B | +11.9% | +19.4% | 9.8% |
WINT Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-84,000 | - | $-25,019,000 | - |
| 2023 | $0 | - | $-82,000 | - | $-17,539,000 | - |
| 2022 | $0 | - | $-1,061,000 | - | $-41,333,000 | - |
| 2021 | $0 | - | $-869,000 | - | $-77,280,000 | - |
| 2020 | $0 | -100.0% | $-638,000 | - | $-30,317,000 | - |
| 2019 | $198K | -88.9% | $185K | 93.6% | $-24,893,000 | -12572.2% |
| 2018 | $1.8M | +20.4% | $-8,774,000 | -490.7% | $-16,195,000 | -905.8% |
| 2017 | $1.5M | -27.3% | $-15,891,000 | -1070.1% | $-22,548,000 | -1518.4% |
| 2016 | $2.0M | +106.9% | $1.8M | 87.5% | $-38,036,000 | -1862.7% |
| 2015 | $987K | -65.2% | $58K | 5.9% | $-39,834,000 | -4035.9% |
See WINT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs WINT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare WINT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonWINT — Frequently Asked Questions
Quick answers to the most common questions about buying WINT stock.
Is WINT's revenue growth accelerating or slowing?
WINT TTM revenue: $90000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is WINT's long-term revenue growth rate?
Windtree Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is WINT's revenue distributed by segment?
WINT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.